泌尿器科領域に於けるヘスナ注射薬の実験的・臨床的研究
スポンサーリンク
概要
- 論文の詳細を見る
Surgical hemorrhage should be controled both with ope r a tive hemostasis and bodily defense mechanisms such as blood coagulation and vascular response. The latter is quite an important factor. Bleeding time, coagulation time, and thrombocytic count were effectively influenced by HESNA administration both in rabbit and man. Urological and postoperative hemorrhage were also well controled with HESNA.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績